be 2254 has been researched along with doxazosin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hatano, A; Lepor, H; Tang, R; Walden, PD | 1 |
| Cotecchia, S; Goepel, M; Hein, P; Michel, MC | 1 |
2 other study(ies) available for be 2254 and doxazosin
| Article | Year |
|---|---|
The alpha-adrenoceptor antagonist properties of the enantiomers of doxazosin in the human prostate.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Binding Sites; Binding, Competitive; Cell Line; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Phenethylamines; Prazosin; Prostate; Radioligand Assay; Receptors, Adrenergic, alpha; Stereoisomerism; Tetralones | 1996 |
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium | 2001 |